Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 6, 2012 - Issue
Submit an article Journal homepage
111
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

Michelle E Orme1 Icera Consulting, Swindon, Wiltshire, UK
,
Katherine S MacGilchrist2 Systematic Review Department, Abacus International, Bicester, Oxfordshire, UKCorrespondence[email protected]
,
Stephen Mitchell2 Systematic Review Department, Abacus International, Bicester, Oxfordshire, UK
,
Dean Spurden3 Pfizer UK Limited, Tadworth, Surrey, UK
&
Alex Bird3 Pfizer UK Limited, Tadworth, Surrey, UK
Pages 429-464 | Published online: 17 Dec 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Jörg Mahlich, Isao Kamae & Rosarin Sruamsiri. (2018) Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 339-348.
Read now
Alfonso E Bello, Elizabeth L Perkins, Randy Jay & Petros Efthimiou. (2017) Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatology: Research and Reviews 9, pages 67-79.
Read now
Hsin-Hua Chen, Der-Yuan Chen, Yi-Ming Chen & Chao-Hsiun Tang. (2016) Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?. Patient Preference and Adherence 10, pages 123-134.
Read now
Alberto Migliore, Emanuele Bizzi, Colin Gerard Egan, Mauro Bernardi & Lea Petrella. (2015) Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis. Therapeutics and Clinical Risk Management 11, pages 1325-1335.
Read now
Toshio Tanaka, Yoshihiro Hishitani & Atsushi Ogata. (2014) Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors. Biologics: Targets and Therapy 8, pages 141-153.
Read now
Yoshiya Tanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Toshiharu Shoji, Nobuyuki Miyasaka & Takao Koike. (2014) Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study. Modern Rheumatology 24:5, pages 725-733.
Read now

Articles from other publishers (2)

Tetsu KOBAYASHI, Kazushige MURAYAMA, Yuki OHTA, Nana KAWASAKI, Satoshi TOYOSHIMA & Akiko ISHII-WATABE. (2017) <b>The Safety Profiles of Biological Drugs for Rheumatoid Arthritis </b>. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 21:2, pages 63-76.
Crossref
David L Scott, Fowzia Ibrahim, Vern Farewell, Aidan G O’Keeffe, Margaret Ma, David Walker, Margaret Heslin, Anita Patel & Gabrielle Kingsley. (2014) Randomised controlled trial of Tumour necrosis factor inhibitors Against Combination Intensive Therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews. Health Technology Assessment 18:66, pages 1-164.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.